Senate Bill S9084

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9084
 
                             I N  S E N A T E
 
                             January 30, 2026
                                ___________
 
 Introduced  by  Sen. PERSAUD -- read twice and ordered printed, and when
   printed to be committed to the Committee on Women's Issues
 
 AN ACT to amend the public health law, in  relation  to  establishing  a
   maternal health monitoring pilot program
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. The public health law is amended by adding  a  new  section
 2500-n to read as follows:
   § 2500-N. MATERNAL HEALTH MONITORING PILOT PROGRAM. 1. AS USED IN THIS
 SECTION:
   (A)  "ELIGIBLE  PARTICIPANT"  MEANS  A  PATIENT  WHO  MEETS ALL OF THE
 FOLLOWING CRITERIA:
   (I) THE PATIENT IS A RECIPIENT OF MEDICAL ASSISTANCE;
   (II) THE PATIENT IS A MEMBER OF A PARTICIPATING MANAGED CARE ORGANIZA-
 TION; AND
   (III) THE PATIENT IS PREGNANT.
   (B) "ESCALATION PATHWAY" MEANS AN AGREEMENT BETWEEN THE  PARTICIPATING
 MANAGED  CARE  ORGANIZATIONS  AND  THE TECHNOLOGY VENDOR ON A PROCESS TO
 FOLLOW WHEN AN ELIGIBLE PARTICIPANT'S MEASUREMENTS  ARE  CONCERNING  AND
 WARRANT FURTHER REVIEW AND INVESTIGATION.
   (C)  "HEALTH  CARE  PROVIDER"  MEANS AN OBSTETRICIAN OR MATERNAL FETAL
 MEDICINE PHYSICIAN WHO MEET ALL OF THE FOLLOWING CRITERIA:
   (I) SUCH PERSON IS LICENSED IN THE STATE OF NEW YORK;
   (II) SUCH PERSON IS  AN  IN-NETWORK  PROVIDER  FOR  THE  PARTICIPATING
 MANAGED CARE ORGANIZATIONS; AND
   (III)  SUCH  PERSON  PROVIDES  CARE FOR AN ELIGIBLE PARTICIPANT DURING
 PREGNANCY.
   (D) "PARTICIPATING MANAGED CARE ORGANIZATION"  MEANS  A  MANAGED  CARE
 ORGANIZATION SELECTED BY THE DEPARTMENT TO ADMINISTER THE PILOT PROGRAM.
   (E) "PILOT PROGRAM" MEANS THE MATERNAL HEALTH MONITORING PILOT PROGRAM
 ESTABLISHED BY THIS SECTION.
   (F)  "REMOTE  MONITORING  CLINICAL CARE TEAM" MEANS A GROUP MADE UP OF
 NURSES LICENSED TO PRACTICE IN NEW YORK STATE, DIETITIANS, AND CERTIFIED
 DIABETES EDUCATION SPECIALISTS WHO ARE MONITORING ELIGIBLE PARTICIPANTS'
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

                                                            LBD14280-01-5
 S. 9084                             2
 
 MEASUREMENTS, AND PROVIDING NUTRITION GUIDANCE, DIABETES  AND  HYPERTEN-
 SION  CONDITION  MANAGEMENT  COUNSELING,  AND  PREGNANCY  AND POSTPARTUM
 ADVICE.
   (G)  "REMOTE PATIENT MONITORING FOR MATERNAL HYPERTENSION AND MATERNAL
 DIABETES" MEANS TECHNOLOGY PROVIDED BY THE TECHNOLOGY VENDOR THAT:
   (I) COLLECTS HEALTH DATA FROM AN ELIGIBLE  PARTICIPANT  AND  ELECTRON-
 ICALLY TRANSMITS THAT INFORMATION SECURELY FOR INTERPRETATION AND RECOM-
 MENDATION;
   (II) USES DEVICES THAT ARE AUTHORIZED BY THE U.S. FOOD AND DRUG ADMIN-
 ISTRATION;
   (III)  MONITORS  HEALTH  DATA, INCLUDING BLOOD PRESSURE, WEIGHT, BLOOD
 GLUCOSE LEVELS, OR OTHER PHYSIOLOGICAL HEALTH DATA AS DETERMINED BY  THE
 ELIGIBLE PARTICIPANT'S HEALTH CARE PROVIDER;
   (IV) TRANSMITS HEALTH DATA THROUGH CELLULAR NETWORKS; AND
   (V)  PROVIDES  PREPROGRAMMED  EQUIPMENT SPECIFICALLY FOR EACH ELIGIBLE
 PARTICIPANT.
   (H) "TECHNOLOGY VENDOR" MEANS A TECHNOLOGY  COMPANY  SELECTED  BY  THE
 DEPARTMENT TO CONTRACT WITH THE PARTICIPATING MANAGED CARE ORGANIZATIONS
 IN ADMINISTERING THE PILOT PROGRAM.
   2.  (A)  A  MATERNAL  HEALTH MONITORING PILOT PROGRAM IS HEREBY ESTAB-
 LISHED WITHIN THE DEPARTMENT TO  OFFER  ELIGIBLE  PARTICIPANTS  IMPROVED
 MATERNAL  HEALTH  CARE  THROUGH  REMOTE  PATIENT MONITORING FOR MATERNAL
 HYPERTENSION AND MATERNAL DIABETES. THE DEPARTMENT SHALL SELECT  ONE  OR
 MORE  PARTICIPATING MANAGED CARE ORGANIZATIONS AND ONE TECHNOLOGY VENDOR
 TO ADMINISTER THE PILOT PROGRAM IN A MANNER  TO  BE  DETERMINED  BY  THE
 DEPARTMENT.
   (B)  EACH  PARTICIPATING  MANAGED  CARE  ORGANIZATION  SHALL  CONTRACT
 DIRECTLY WITH THE TECHNOLOGY VENDOR TO OFFER REMOTE  PATIENT  MONITORING
 FOR MATERNAL HYPERTENSION AND MATERNAL DIABETES AND ENSURE THAT ELIGIBLE
 PARTICIPANTS HAVE ACCESS TO THE PILOT PROGRAM.
   (C)  THE  TECHNOLOGY VENDOR SHALL MEET THE FOLLOWING REQUIREMENTS WHEN
 OFFERING REMOTE PATIENT MONITORING FOR MATERNAL HYPERTENSION AND  MATER-
 NAL DIABETES TO AN ELIGIBLE PARTICIPANT UNDER THE PILOT PROGRAM:
   (I)  ENSURING THAT REMOTE PATIENT MONITORING FOR MATERNAL HYPERTENSION
 AND MATERNAL DIABETES IS POSSIBLE DURING PREGNANCY AND FOR UP  TO  THREE
 MONTHS POSTPARTUM;
   (II)  ENSURING THAT A REMOTE PATIENT MONITORING DEVICE IS DELIVERED TO
 EACH ELIGIBLE PARTICIPANT;
   (III) ENSURING THAT EACH ELIGIBLE PARTICIPANT IS TRAINED ON HOW TO USE
 THE REMOTE PATIENT MONITORING DEVICE;
   (IV) ASSIGNING A PROGRAM MANAGER TO  SUPPORT  THE  IMPLEMENTATION  AND
 ADMINISTRATION OF THE PROGRAM AND TO COORDINATE EFFORTS WITH THE PARTIC-
 IPATING MANAGED CARE ORGANIZATIONS AND THE DEPARTMENT; AND
   (V)  EMPLOYING  A REMOTE MONITORING CLINICAL CARE TEAM THAT IS CAPABLE
 OF:
   (A) MONITORING AND REVIEWING ELIGIBLE PARTICIPANT'S HEALTH DATA;
   (B) CREATING AN ESCALATION PATHWAY WITH THE PARTICIPATING MANAGED CARE
 ORGANIZATIONS IF THE ELIGIBLE PARTICIPANT'S  REMOTE  PATIENT  MONITORING
 READINGS,  IN  CONJUNCTION  WITH  THE  ELIGIBLE  PARTICIPANT'S SYMPTOMS,
 REQUIRE ADDITIONAL MEDICAL ATTENTION;
   (C) PROVIDING HEALTH COACHING TO  PARTICIPANTS  IN  MATTERS  INCLUDING
 NUTRITION, CONDITION MANAGEMENT, AND HEALTHY BEHAVIOR MODIFICATION; AND
   (D)  COORDINATING WITH THE ELIGIBLE PARTICIPANT'S HEALTH CARE PROVIDER
 AS NEEDED.
   3. (A) THE DEPARTMENT SHALL IMPLEMENT THE PILOT  PROGRAM  IN  AS  MANY
 COUNTIES  AS  NECESSARY  TO  ENSURE  PARTICIPATION OF UP TO FIVE HUNDRED
 S. 9084                             3
 
 ELIGIBLE PARTICIPANTS.  THE  PROGRAM  MUST  INCLUDE  COUNTIES  THAT  ARE
 CONSIDERED  MATERNITY  CARE  DESERTS  BASED ON THE MARCH OF DIMES LATEST
 MATERNITY CARE DESERT REPORT.
   (B)  THE  PILOT PROGRAM SHALL BE OPERATIONAL NO LATER THAN ONE HUNDRED
 EIGHTY DAYS AFTER THE CONTRACT DATE BETWEEN  THE  PARTICIPATING  MANAGED
 CARE  ORGANIZATION  AND  THE  TECHNOLOGY  VENDOR. THE PILOT PROGRAM WILL
 CONCLUDE TWO YEARS AFTER THE PILOT PROGRAM IS OPERATIONAL.
   4. THE DEPARTMENT SHALL PAY A FEE TO THE  PARTICIPATING  MANAGED  CARE
 ORGANIZATIONS TO ADMINISTER THE PILOT PROGRAM. THE PARTICIPATING MANAGED
 CARE  ORGANIZATIONS  SHALL  USE  THE  FEE  PAYMENT TO COVER THE COSTS OF
 CONTRACTING WITH THE  TECHNOLOGY  VENDOR  AND  ADMINISTERING  THE  PILOT
 PROGRAM.  THE  DEPARTMENT  SHALL PROVIDE SIX HUNDRED THOUSAND DOLLARS TO
 OFFSET THE COSTS OF THE PILOT PROGRAM.
   5. (A) WITHIN TWO YEARS OF THE  PILOT  PROGRAM'S  IMPLEMENTATION,  THE
 DEPARTMENT  SHALL COLLABORATE WITH THE PARTICIPATING MANAGED CARE ORGAN-
 IZATIONS AND ANY OTHER RELEVANT STAKEHOLDERS  TO  DEVELOP  A  REPORT  ON
 EVALUATING  THE  OUTCOMES  OF THE PILOT PROGRAM. THE REPORT WILL LOOK AT
 AVAILABLE DATA OF PROGRAM PARTICIPANTS,  INCLUDING  CLAIMS  DATA,  VITAL
 STATS DATA, EHR/EMR DATA, TO DETERMINE THE PILOT PROGRAM'S IMPACT ON THE
 FOLLOWING  MATERNAL,  FETAL  AND  NEONATAL  HEALTH OUTCOMES TO DETERMINE
 WHETHER THE PROGRAM IMPROVES MATERNAL, FETAL  AND  NEONATAL  HEALTH  AND
 WHETHER THE PROGRAM WILL LEAD TO SAVINGS TO MEDICAID.
   (B)  MATERNAL OUTCOMES TO BE CONSIDERED SHALL INCLUDE MATERNAL MORTAL-
 ITY RATE, SEVERE MATERNAL MORBIDITY RATE,  INCIDENCES  OF  PREECLAMPSIA,
 THE CESARIAN SECTION RATE, THE MEAN LENGTH OF THE ELIGIBLE PARTICIPANTS'
 HOSPITAL  STAYS, THE INTENSIVE CARE UNIT ADMISSION RATE, THE MEAN LENGTH
 OF THE INTENSIVE CARE UNIT STAY, AND THE POSTPARTUM HOSPITAL READMISSION
 RATE. FETAL/NEONATAL OUTCOMES TO BE CONSIDERED SHALL INCLUDE  THE  FETAL
 MORTALITY  RATE,  THE  RATE  OF  FETAL  GROWTH RESTRICTION, THE NEONATAL
 MORTALITY RATE, THE NICU ADMISSIONS RATE, THE MEAN LENGTH OF NICU  STAY,
 THE  RATE  OF  NEONATAL HYPOGLYCEMIA, THE PRETERM BIRTH RATE, THE GESTA-
 TIONAL AGE AT DELIVERY, AND THE BIRTHWEIGHT.
   (C) THE REPORT WILL  INCLUDE  RECOMMENDATIONS  REGARDING  WHETHER  THE
 PILOT PROGRAM SHOULD BE EXPANDED THROUGHOUT NEW YORK.
   (D) THE DEPARTMENT SHALL SUBMIT THE REPORT TO THE GOVERNOR, THE PRESI-
 DENT OF THE SENATE, THE SPEAKER OF THE ASSEMBLY, THE CHAIR OF THE ASSEM-
 BLY  COMMITTEE  ON HEALTH, THE CHAIR OF THE ASSEMBLY COMMITTEE ON INSUR-
 ANCE, THE CHAIR OF THE SENATE COMMITTEE ON  HEALTH,  THE  CHAIR  OF  THE
 SENATE  COMMITTEE  ON INSURANCE AND THE CHAIR OF THE SENATE COMMITTEE ON
 WOMEN'S ISSUES.
   § 2. This act shall take effect on the sixtieth  day  after  it  shall
 have become a law.